BioLargo, Inc. (BLGO)
OTCMKTS · Delayed Price · Currency is USD
0.1870
-0.0030 (-1.58%)
Jul 21, 2025, 3:50 PM EDT
BioLargo Revenue
BioLargo had revenue of $3.27M in the quarter ending March 31, 2025, a decrease of -31.32%. This brings the company's revenue in the last twelve months to $16.29M, up 22.95% year-over-year. In the year 2024, BioLargo had annual revenue of $17.78M with 45.37% growth.
Revenue (ttm)
16.29M
Revenue Growth
+22.95%
P/S Ratio
3.51
Revenue / Employee
387.81K
Employees
44
Market Cap
57.24M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.78M | 5.55M | 45.37% |
| Dec 31, 2023 | 12.23M | 6.35M | 107.85% |
| Dec 31, 2022 | 5.88M | 3.35M | 132.48% |
| Dec 31, 2021 | 2.53M | 99.00K | 4.07% |
| Dec 31, 2020 | 2.43M | 571.00K | 30.68% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The Monarch Cement Company | 256.69M |
| Gold Reserve | 3.17M |
| Panamera Holdings | 212.04K |
| Rubber Leaf | 3.98M |
| Cardinal Ethanol, LLC | 350.34M |
| Venator Materials | 1.56B |
| Webco Industries | 577.86M |
BioLargo News
- 20 days ago - BioLargo Initiates Alpha Testing of Verralize's Portable PFAS Test Kit to Validate Performance for Future Commercialization - Accesswire
- 25 days ago - BioLargo Announces Results of 2025 Annual Stockholder Meeting - Accesswire
- 4 weeks ago - Independent Evaluation Confirms Breakthrough Performance of BioLargo's Cellinity Battery Technology for Grid-Scale Energy Storage - Accesswire
- 2 months ago - BioLargo Q1 2025 Earnings Results Webcast and Conference Call on Thursday, May 15, 2025 - 4:30 PM Eastern Time - Accesswire
- 2 months ago - BioLargo Subsidiary Clyra Medical Advances Product Distribution Through a Series of Agreements - Accesswire
- 2 months ago - BioLargo's PFAS Solution Provides Dramatic Long-Term Cost Savings Compared with Incumbent Technologies - Accesswire
- 3 months ago - BioLargo to Present at the LD Micro Invitational XV - Newsfile Corp
- 3 months ago - Cleantech Innovator BioLargo Reports Record Revenues in 2024 Annual Report - Accesswire